OTCMKTS:PURE

PURE Bioscience (PURE) Stock Price, News & Analysis

PURE Bioscience logo
$0.06 -0.01 (-14.29%)
As of 03:50 PM Eastern

About PURE Bioscience Stock (OTCMKTS:PURE)

Advanced

Key Stats

Today's Range
$0.06
▼
$0.07
50-Day Range
$0.06
▼
$0.09
52-Week Range
$0.04
▼
$0.10
Volume
38,070 shs
Average Volume
21,423 shs
Market Capitalization
$7.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PURE Bioscience develops and commercializes antimicrobial products based on silver dihydrogen citrate (SDC), a proprietary formulation designed to control bacteria and other microorganisms. The company focuses on applications where surface hygiene and food safety are important.

Its offerings include SDC-based disinfectant and sanitizer products for hard surfaces, including products intended for food-processing and food-service environments. PURE Bioscience also pursues commercial partnerships to market its technology and products.

The company’s business centers on developing uses for its SDC technology across professional settings such as food handling and sanitation. Product availability and applications may vary by market and regulatory requirements.

AI Generated. May Contain Errors.

PURE Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

PURE MarketRank™: 
1.45430463576 of 5 stars

PURE Bioscience scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for PURE Bioscience.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PURE Bioscience is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PURE Bioscience is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.00% of the float of PURE Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    PURE Bioscience has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PURE Bioscience has recently decreased by 54.76%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    PURE Bioscience does not currently pay a dividend.

  • Dividend Growth

    PURE Bioscience does not have a long track record of dividend growth.

  • News Sentiment

    PURE Bioscience has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for PURE Bioscience this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for PURE on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PURE Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    35.56% of the stock of PURE Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    PURE Bioscience has minimal institutional ownership at this time.

  • Read more about PURE Bioscience's insider trading history.
Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PURE Stock News Headlines

Purecore Adds Jeremy S. Brett as Technical Advisor
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
PURE Bioscience Reports Fiscal 2026 Financial Results
Pure Bioscience Inc.
See More Headlines

PURE Stock Analysis - Frequently Asked Questions

PURE Bioscience's stock was trading at $0.0420 at the beginning of the year. Since then, PURE stock has increased by 42.9% and is now trading at $0.06.

PURE Bioscience (OTCMKTS:PURE) posted its quarterly earnings data on Monday, June, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $510 thousand for the quarter.

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PURE Bioscience investors own include Aurora Cannabis (ACB), Novavax (NVAX), Cresco Labs (CRLBF), Aurora Cannabis (ACB), Canopy Growth (CGC), DraftKings (DKNG) and Broadcom (AVGO).

Company Calendar

Today
11/16/2026
Fiscal Year End
7/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:PURE
CIK
1006028
Employees
11
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.48 million
Net Margins
-107.12%
Pretax Margin
-107.12%
Return on Equity
N/A
Return on Assets
-210.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.27
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$2.32 million
Price / Sales
3.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.05) per share
Price / Book
-1.20

Miscellaneous

Outstanding Shares
130,020,000
Free Float
83,784,000
Market Cap
$7.80 million
Optionable
Not Optionable
Beta
0.34

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:PURE) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners